Skip to content

High-flow Nasal Cannula Oxygenation During Rapid Sequence Induction in Children

A Randomised Controlled Trial Comparing Pre-oxygenation Strategies With High-flow Humidified Nasal Oxygenation Versus Apnoeic Facemask Oxygenation During Rapid Sequence Induction in Children Aged Less Then 11 Years

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05063084
Acronym
OPTINECK
Enrollment
44
Registered
2021-09-30
Start date
2023-02-09
Completion date
2024-02-06
Last updated
2026-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Surgery, Rapid Sequence Induction

Keywords

nasal high flow oxygen, rapid sequence induction, preoxygenation, pediatric

Brief summary

This randomised study aims to compare the utilization of high-flow humidified nasal oxygenation (HFNO) with standard care, using apnoeic facemask oxygenation, during rapid sequence induction (RSI) of anesthesia in young children. 170 children aged less then 11 years, admitted to the operating room for surgery and with a medical indication of a RSI of anesthesia will be recruited in one university hospital (Necker-Enfants-Malades in Paris). Children will be randomly assigned into two groups: the control group will benefit of standard care and the HFNO group will receive heated and humidified oxygen through a nasal cannula device during pre-oxygenation and apnoea time prior to tracheal intubation. HFNO has been evaluated and showed benefits in rapid sequence induction of anesthesia in adults and prolonged apnea time before desaturation in children. To the investigators' knowledge the potential benefit of HFNO during RSI in young children remain to be evaluated.

Detailed description

Hypoxic events during rapid sequence induction (RSI) in children remain more frequent than during standard induction. Although the exact incidence is difficult to appreciate. However the deleterious consequences of hypoxemia during tracheal intubation procedures are well known. HFNO is an effective technique to supplement oxygen including during apnoea. Studies in children have shown benefits both during breathing and apneic situation. A monocentric controlled randomized study including children, aged less then 11 years, will be conducted in order to assess the potential benefits of this technique during RSI. The rate of successful tracheal intubation without oxygen desaturation is the primary outcome. Children will be randomly assigned into two groups: * The control group will benefit of standard RSI. Pre-oxygenation will be given through facemask with 100% oxygen during 2 minutes, with a flow of 6 to 8 L.min-1 depending on the age of the child. No oxygen will be delivered during laryngoscopy. * The HFNO group will be given 2 L.Kg-1.min-1 of humidified and heated 100% O2 through a nasal cannula during a 2 minutes pre-oxygenation and then throughout laryngoscopy. Adverse events will be recorded and follow-up continued until discharge from the post anesthesia care unit (PACU).

Interventions

PROCEDUREOptiflow - HFNO

Pre-oxygenation: HFNO with a 2 L/Kg/min flow during 2 min with 100% FiO2 Oxygenation: during the tracheal intubation, HFNO with a 2 L/Kg/min flow during 2 min with 100% FiO2

PROCEDUREClassic

Pre-oxygenation: with facemask during 2 min with 100% FiO2, flow 6 to 8L/min. No oxygenation during the tracheal intubation

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER
URC-CIC Paris Descartes Necker Cochin
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 10 Years
Healthy volunteers
No

Inclusion criteria

* child from birth until 10 years * patient needing (elective or in emergency) surgery under general anesthesia requiring tracheal intubation and fulfilling all criteria for a rapid sequence induction * Parents or legal guardians signed the Informed consent form * Social insurance affiliation

Exclusion criteria

\- child having one or more contraindication to use high flow nasal oxygenation: * Nasal obstruction * Recent trauma of aero-digestives tracts * Epistaxis * Known or suspected fracture of the skull base * Cephalo-spinal fluid leak or all other communication between nasal space and intracranial space * Tuberculosis or other nasal or lung infection * Pneumothorax or pneumo-mediastin documented or suspected * Complete limitation of mouth opening

Design outcomes

Primary

MeasureTime frameDescription
Intubation without oxygen desaturation episodeUp to 10 minutesIntubation without oxygen desaturation episode, defined as pulsed oxymetry \<95% during the rapid sequence induction process of anesthesia in the operating room.

Secondary

MeasureTime frameDescription
Oxygen saturation levelUp to 10 minutesMeasurement of the lowest oxygen saturation during the tracheal intubation process
Tracheal intubation without facemask reventilationUp to 10 minutesTracheal intubation without facemask reventilation
Number of attempted tracheal intubations required to succeed the processUp to 10 minutesNumber of attempted tracheal intubations required to succeed the process
Occurrence of all adverse eventsuntil the exit of the recovery roomOccurrence of all adverse events during tracheal intubation in the operating room (linked or not to the use of HFNO)
Satisfaction of the anaesthetist and the anaesthesia team regarding the use of HFNOExit of the recovery roomQuestionnaire about satisfaction, the use of the procedure, stress level and potential genes

Countries

France

Contacts

STUDY_CHAIRGilles ORLIAGUET, MD, PhD

Assistance Publique - Hôpitaux de Paris

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 7, 2026